Byar D - Search Results

1

Tryptophan metabolites, pyridoxine (vitamin B6) and their influence on the recurrence rate of superficial bladder cancer. Results of a prospective, randomised phase III study performed by the EORTC GU Group. EORTC Genito-Urinary Tract Cancer Cooperative Group.

Newling DW, Robinson MR, Smith PH, Byar D, Lockwood R, Stevens I, De Pauw M, Sylvester R. Newling DW, et al. Among authors: byar d. Eur Urol. 1995;27(2):110-6. doi: 10.1159/000475139. Eur Urol. 1995. PMID: 7744151 Clinical Trial.

2

Using permutation tests and bootstrap confidence limits to analyze repeated events data from clinical trials.

Freedman L, Sylvester R, Byar DP. Freedman L, et al. Among authors: byar dp. Control Clin Trials. 1989 Jun;10(2):129-41. doi: 10.1016/0197-2456(89)90026-3. Control Clin Trials. 1989. PMID: 2752763

3

A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group.

Byar DP, Green SB, Dor P, Williams ED, Colon J, van Gilse HA, Mayer M, Sylvester RJ, van Glabbeke M. Byar DP, et al. Eur J Cancer (1965). 1979 Aug;15(8):1033-41. doi: 10.1016/0014-2964(79)90291-3. Eur J Cancer (1965). 1979. PMID: 510341 No abstract available.

4

Statistical analysis techniques and sample size determination for clinical trials of treatments for bladder cancer.

Byar D, Kaihara S, Sylvester R, Freedman L, Hannigan J, Koiso K, Oohashi Y, Tsugawa R. Byar D, et al. Prog Clin Biol Res. 1986;221:49-64. Prog Clin Biol Res. 1986. PMID: 3809188 No abstract available.

5

Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancer.

Byar D, Blackard C. Byar D, et al. Urology. 1977 Dec;10(6):556-61. doi: 10.1016/0090-4295(77)90101-7. Urology. 1977. PMID: 414402 Clinical Trial.

6

Results of a clinical trial of surgery and radiation in stages II and 3 carcinoma of the bladder.

Blackard CE, Byar DP. Blackard CE, et al. Among authors: byar dp. J Urol. 1972 Dec;108(6):875-8. doi: 10.1016/s0022-5347(17)60895-4. J Urol. 1972. PMID: 5082739 No abstract available.

7

Estrogen dosage and suppression of testosterone levels in patients with prostatic carcinoma.

Kent JR, Bischoff AJ, Arduino LJ, Mellinger GT, Byar DP, Hill M, Kozbur X. Kent JR, et al. Among authors: byar dp. J Urol. 1973 May;109(5):858-60. doi: 10.1016/s0022-5347(17)60564-0. J Urol. 1973. PMID: 4699685 Clinical Trial. No abstract available.

8

Cancer of the prostate in men less than 50 years old: an analysis of 51 cases.

Byar DP, Mostofi FK. Byar DP, et al. J Urol. 1969 Dec;102(6):726-33. doi: 10.1016/s0022-5347(17)62240-7. J Urol. 1969. PMID: 5372026 No abstract available.

9

Carcinoma of prostate. Correlation between radiologic quantitation of metastases and patient survival.

Hovsepian JA, Byar DP. Hovsepian JA, et al. Among authors: byar dp. Urology. 1975 Jul;6(1):11-6. doi: 10.1016/0090-4295(75)90584-1. Urology. 1975. PMID: 1145912

10

Clinical trials in diet and cancer.

Byar DP, Freedman LS. Byar DP, et al. Prev Med. 1989 Mar;18(2):203-19. doi: 10.1016/0091-7435(89)90067-4. Prev Med. 1989. PMID: 2740291

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page